VCID: 105179
Profile
Corporate information
Official name
Crescendo Biologics Limited
Registration country
Official name
Crescendo Biologics Limited
Registration country
Investment activity status
Active investor
Company type
Exploits its class-leading next generation antibody platform to create differentiated medicines developed to Phase I/II.Funding
Funding rounds
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Bessemer Venture Partners | Early stage venture capital firm. | United States |
Cap Table
Current and past shareholders
| Investor | Contacts | Round | |
|---|---|---|---|
|
|
Bessemer Venture Partners Early stage venture capital firm. |
+1 (650) 853-7000 |
N/A |
|
Midven Ltd |
+44 (121) 710-1990 |
N/A |